Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Guangdong Topstar Technology
300607
5
Hengerda New Materials
300946
CN Stock MarketDetailed Quotes
688617 APT Medical Inc.
- 399.01
- -11.47-2.79%
Market Closed May 12 15:00 CST
38.74BMarket Cap54.09P/E (TTM)
412.78High397.08Low6.89KlotVolume410.55Open410.48Pre Close275.28MTurnover0.71%Turnover Ratio57.54P/E (Static)97.08MShares480.0052wk High14.34P/B38.74BFloat Cap292.5452wk Low492.58Limit Up97.08MShs Float480.00Historical High328.38Limit Down3.83%Amplitude94.85Historical Low1.38Dividend TTM399.79Avg Price3.93KlotAsk0.35%Div YieldTTM100Lot Size1.99KlotBid
APT Medical Inc. News
Announcement on the results of some senior management\'s share holdings reduction
Announcement on the 2024 Profit Distribution and Capital Provident Fund Share Capital Transfer Plan
Announcement of plans to reduce share holdings of some senior management
Announcement on the implementation of share repurchase cancellation and share changes
Announcement on the first grant and reserve portion of the company\'s 2021 restricted stock incentive plan to grant the first vesting period for Class A restricted shares, the second vesting period for Class B restricted stocks, and the second ownership results and stock listing
Legal Opinion on the Adjustment of Grant Price, Grant Quantity, and Attribution of Restricted Stock Incentive Plan for 2021 of apt medical inc., Shenzhen, issued by Jia Yuan Law Firm, Peking.
Announcement Regarding Adjustment of Grant Price, Grant and Allocation Quantity of Restricted Stock Incentive Plan for 2021
Announcement of Annual Equity Distribution Implementation in 2023
Announcement on Adjusting the Total Amount of Cash Dividends and the Total Amount of Capital Reserve Transferred to Share Capital in the Profit Distribution of 2023
Announcement of the first grant of and reserved grant of Class A Restricted Stocks and the first grant result of Class B Restricted Stocks in the restricted stock incentive plan of the company for 2021 and the listing of shares.
Announcement regarding the first granting and reserved partial granting of type A restricted stocks and type B restricted stocks for the first and second vesting periods, respectively, of the company's restricted stock incentive plan for 2021.
Legal Opinion on the first grant of restricted stocks and reserved grant of restricted stocks, achievement of ownership conditions for the first vesting period of Class A restricted stocks and the second vesting period of Class B restricted stocks, and the cancellation of some restricted stocks related matters for Shenzhen Apt Medical Inc.'s 2021 restricted stock incentive plan for medical instruments
The Supervisory Board's opinion on the verification of the first attribution period of the restricted stock incentive plan for the company in 2021, as well as the reserved grant of A-type restricted stocks and the second attribution period of B-type restricted stocks.
Announcement regarding the cancellation of the portion of the 2021 restricted stock incentive plan that has been granted but not yet vested.
Announcement on completion of share transfer
Announcement on the 2023 Profit Distribution and Capital Provident Fund Share Capital Transfer Plan
Simplified Equity Change Report (Revised Edition)
Progress announcement on changes in shareholders' equity
Simplified Statement of Changes in Equity
An indicative announcement on changes in shareholders\' equity and proposed changes in controlling shareholders and actual controllers
Market Insights
Discussing
Berkshire 2025 highlights: Stepping aside as CEO, trade and market volatility
$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve
Buffettttttt
May 3 21:00
Berkshire's 2025 Annual Shareholders Meeting